Armata Pharmaceuticals Inc banner

Wall St Price Targets

TG1N Price Forecast
Based on 3 analysts

+461% Upside
from €3.4 today

Armata Pharmaceuticals Inc (TG1N)’s 12-month stock price forecast through October 2027 has a consensus target of €19.08, implying 461% upside. The forecast is based on price targets from 3 Wall Street analysts.

TG1N Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for TG1N yet.

Armata Pharmaceuticals Inc Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TG1N's stock price target?
Price Target
19.08 EUR

According to Wall Street analysts, the average 1-year price target for TG1N is 19.08 EUR with a low forecast of 16.19 EUR and a high forecast of 22.44 EUR.

What is the Revenue forecast for Armata Pharmaceuticals Inc?
Projected CAGR
73%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 73%.

Back to Top